2438 Results for "

decrease

" in MedChemExpress (MCE) Product Catalog:
Products (2438)

2438 Results for "decrease" in MCE Product Catalog:

Referencia número: HY-128395
No. CAS: 917104-47-3
Synonyms: C20-DHSM; DHSM (d18:0/20:0)
Áreas de investigación:  

Others

C20-Dihydrosphingomyelin (C20-DHSM; DHSM (d18:0/20:0)) is a saturated form of Sphingomyelin (HY-113498). C20-Dihydrosphingomyelin is a secondary component of most cell sphingolipids and its levels significantly decrease after intermittent fasting during Ramadan. C20-Dihydrosphingomyelin can be used for the development of liposome reagents .
loading...
    loading...
Referencia número: HY-129245
No. CAS: 78466-98-5
Synonyms: Hoe 175
Target:  

Endogenous Metabolite

Áreas de investigación:  

Neurological Disease

Razobazam (Hoe 175) is a benzodiazepine derivative with cognitive activity. Razobazam has been shown to improve learning performance in socially deprived rats. Razobazam increased avoidance scores by 18% after training. Razobazam caused significant changes in the optical density of certain areas of the rat brain, including a 22% decrease in the lateral habenula and a 25% increase in the ventral tegmental area. Razobazam also caused a 13% increase in optical density in the prefrontal cortex of rats .
loading...
    loading...
Referencia número: HY-132972
No. CAS: 2866261-50-7
Áreas de investigación:  

Cancer

TrxR-IN-2 is a thioredoxin reductase (TrxR) inhibitor. TrxR-IN-2 increases reactive oxidative species (ROS) levels and decreases mitochondrial transmembrane potential levels. TrxR-IN-2 triggers DNA damage via H2AX regulation, and induces autophagy via LC3, beclin-1, and p62 regulation. TrxR-IN-2 can be used for the research of drug-resistant hepatocellular carcinoma[1].
loading...
    loading...
Referencia número: HY-133180
No. CAS: 2131223-64-6
Pureza:  99.38%
Target:  

Wnt β-catenin

Áreas de investigación:  

Metabolic Disease

YW1128 (compound 3a) is a potent Wnt/β-Catenin inhibitor. YW1128 induces the proteasome degradation of β-catenin and subsequent inhibits the Wnt/β-catenin signaling in cells. YW1128 significantly decreases hepatic lipid accumulation. YW1128 improves glucose tolerance of high fat diet-fed mice without noticeable toxicity. YW1128 down regulates the genes involved in the glucose and fatty acid anabolism .
loading...
    loading...
Referencia número: HY-134269
No. CAS: 189876-06-0
Synonyms: 7-Deaza-8-bromo-cADPR; 7-Deaza-8-bromo-cyclic ADP ribose
Target:  

Calcium Channel

Áreas de investigación:  

Neurological Disease

8-Br-7-CH-cADPR (7-Deaza-8-bromo-cADPR) is a potent cADPR antagonist. 8-Br-7-CH-cADPR shows partial inhibition of calcium elevation caused by sTIR dimerization. 8-Br-7-CH-cADPR significantly decreases Paclitaxel (HY-B0015)-induced axon degeneration .
loading...
    loading...
Referencia número: HY-13671R
No. CAS: 934593-90-5
Synonyms: HIF-1α inhibitor (Standard); LW8 (Standard)
Áreas de investigación:  

Cancer

LW6 (Standard) is the analytical standard of LW6 (HY-13671). This product is intended for research and analytical applications. LW6 (HIF-1α inhibitor) is a novel HIF-1 inhibitor with an IC50 value of 4.4 μM, and it is also an inhibitor of MDH2. LW6 decreases HIF-1α protein expression without affecting HIF-1β expression.
loading...
    loading...
Referencia número: HY-141852
No. CAS: 896683-78-6
Pureza:  98.37%
Target:  

Deubiquitinase

Áreas de investigación:  

Inflammation/Immunology

STAMBP-IN-1 is a small-molecule inhibitor of STAMBP deubiquitinase, and interrupts STAMBP-Ub-NALP7 interaction. STAMBP-IN-1 decreases protein level of its inflammasome substrate NALP7 and suppresses IL-1b release after Toll-like receptor (TLR) agonism. STAMBP-IN-1 inhibits the activity of STAMBP to cleave recombinant di-Ub with an IC50 value of 0.33 mM .
loading...
    loading...
Referencia número: HY-146151
No. CAS: 2204249-82-9
Target:  

γ-secretase Amyloid-β

Áreas de investigación:  

Neurological Disease

γ-Secretase modulator 12 (Compound 1a) is a γ-secretase modulator that can selectively decrease amyloid-β42 (Aβ42) levels (IC50 of 0.39 µM). γ-Secretase modulator 12 can be used for Alzheimer’s disease research. γ-Secretase modulator 12 has a good brain/plasma ratio (Kp, brain = 0.72) in mice .
loading...
    loading...
Referencia número: HY-14648S1
Synonyms: Hexadecadrol-d5-1; Prednisolone F-d5-1
Dexamethasone-d5-1 is deuterium labeled Dexamethasone. Dexamethasone (Hexadecadrol) is a glucocorticoid receptor agonist. Dexamethasone also significantly decreases CD11b, CD18, and CD62L expression on neutrophils, and CD11b and CD18 expression on monocytes. Dexamethasone is highly effective in the control of COVID-19 infection. Dexamethasone inhibits production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.
loading...
    loading...
Referencia número: HY-14648S2
No. CAS: 2305607-27-4
Synonyms: Hexadecadrol-d4; Prednisolone F-d4
Dexamethasone-d4 is deuterium labeled Dexamethasone. Dexamethasone (Hexadecadrol) is a glucocorticoid receptor agonist. Dexamethasone also significantly decreases CD11b, CD18, and CD62L expression on neutrophils, and CD11b and CD18 expression on monocytes. Dexamethasone is highly effective in the control of COVID-19 infection. Dexamethasone inhibits production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.
loading...
    loading...
Referencia número: HY-147127
No. CAS: 2419180-34-8
Target:  

Bacterial ATP Synthase

Áreas de investigación:  

Infection

WEN05-03 is a EscN ATPase inhibitor. WEN05-03 blocks the active site of EscN ATPase and competitively inhibits its ATP hydrolysis activity. WEN05-03 completely blocks actin cluster formation, reduces actin pedestal formation, and decreases the toxicity of infected mammalian cells. WEN05-03 can be used in studies related to enteropathogenic E. coli (EPEC) infection .
loading...
    loading...
Referencia número: HY-147195
No. CAS: 2754254-07-2
QH536 is a degrader of HMG-CoA reductase (HMGCR) with an EC50 of 0.22 μM. QH536 induces ubiquitination and degradation of HMGCR via the ubiquitin-proteasome pathway, inhibits cholesterol biosynthesis, reduces cholesterol levels, suppresses hepatic stellate cell proliferation, and decreases the expression of fibrotic and inflammatory genes/proteins without inducing intracellular cholesterol accumulation. QH536 can be used in the research of cardiovascular diseases and non-alcoholic steatohepatitis (NASH) .
loading...
    loading...
Referencia número: HY-147428
No. CAS: 188125-42-0
Pureza:  99.29%
Synonyms: MM-110; (±)​-18-Methoxycoronaridine
Target:  

nAChR Parasite

Áreas de investigación:  

Infection Neurological Disease

Zolunicant (MM-110) is a potent inhibitor against nicotinic α3β4 receptors with an IC50 of 0.90 μM to combat addiction. Zolunicant can decrease the self-administration of several addictive agents including morphine, methamphetamine, nicotine, and ethanol in rat model. Zolunicant can be studied as a potential research for multiple forms of agent abuse . Zolunicant also reveals a potent leishmanicide effect against Leishmania amazonensis .
loading...
    loading...
Referencia número: HY-147548
No. CAS: 2445349-54-0
Áreas de investigación:  

Others

Keap1-Nrf2-IN-10 (compound 15) is a potent NQO1 inducer. Keap1-Nrf2-IN-10 inhibits oxidative stress by decreasing the levels of MDA, ROS, NQO1 in the liver for gamma-irradiated mice. Keap1-Nrf2-IN-10 improves the survival of gamma-irradiated mice .
loading...
    loading...
Referencia número: HY-149635
Áreas de investigación:  

Cancer

HIF-1α-IN-6 (compound 3s) is a HIF-1α inhibitor with IC50 values of 0.6 and 53.3 nM observed in MiaPaCa-2 and MDA-MB-231 cells. HIF-1α-IN-6 can inhibit HIF-1α expression by decreasing the level of HIF-1α mRNA .
loading...
    loading...
Referencia número: HY-158036
No. CAS: 3023095-61-3
Target:  

PROTACs STING IKK IFNAR CXCR

Áreas de investigación:  

Inflammation/Immunology

PROTAC STING Degrader-2 is a STING PROTAC degrader with a DC50 of 0.53 μM. PROTAC STING Degrader-2 reduces the phosphorylation levels of TBK1 and IRF3. PROTAC STING Degrader-2 decreases the mRNA expression levels of IFN-β, CXCL10 and TNF-α, and blocks luciferase secretion. PROTAC STING Degrader-2 can be used in the research of autoimmune diseases .
loading...
    loading...
Referencia número: HY-158368
No. CAS: 2566976-43-8
Áreas de investigación:  

Cancer

PRDX1-IN-2 (compound 15) is a selective inhibitor of the antioxidant enzyme Peroxiredoxin 1 (PRDX1) (IC50=0.35 μM). PRDX1-IN-2 decreases the mitochondria membrane potential of SW620 cells, probably due to ROS induced by PRDX1 inhibition, leading to cell apoptosis. PRDX1-IN-2 can be used for colorectal cancer research .
loading...
    loading...
Referencia número: HY-163689
No. CAS: 1868065-21-7
Synonyms: BI 690517
Target:  

Cytochrome P450

Áreas de investigación:  

Cardiovascular Disease Metabolic Disease

Vicadrostat (BI 690517) is an orally active aldosterone synthase (aldosterone synthase) inhibitor, with IC50 values of 19 nM, 16 nM, and 18 μM against human, cynomolgus monkey, and rat aldosterone synthase, respectively. Vicadrostat has an in vivo IC50 of 25 nM for aldosterone synthesis. Vicadrostat exhibits high selectivity for cortisol synthase; it reduces aldosterone production and decreases plasma aldosterone levels. Vicadrostat can be used in the research of chronic kidney disease, heart failure, and hypertension .
loading...
    loading...
Referencia número: HY-164483
No. CAS: 1462329-41-4
Target:  

Akt Trk Receptor

Áreas de investigación:  

Cancer

HS-345 is a TrkA/Ak inhibitor with significant anti-pancreatic cancer effects. HS-345 inhibits the growth and proliferation of pancreatic cancer cells by targeting the TrkA/Akt signaling pathway, while also inducing apoptosis. Additionally, HS-345 suppresses blood vessel formation by decreasing the expression of HIF-1α and VEGF. HS-345 holds promise for research in pancreatic cancer .
loading...
    loading...
Referencia número: HY-164520
No. CAS: 491828-75-2
Target:  

Wnt

Áreas de investigación:  

Cancer

PMED-1 is a β-catenin inhibitor that significantly reduces β-catenin activity in hepatoblastoma cells and various HCC cells, with an IC50 value ranging from 4.87 to 32 μM. PMED-1 affects Wnt signaling by decreasing the interaction between β-catenin and CREB binding protein, thereby inhibiting cell proliferation. PMED-1 has potential applications in cancer research .
loading...
    loading...